Experienced in Warts

Chalid Assaf

Hamburg, HH, DE 
Experienced in Warts
Hamburg, HH, DE 
OverviewLocationsClinical Research

Overview

Chalid Assaf practices in Hamburg, Germany. Assaf is rated as an Experienced expert by MediFind in the treatment of Warts. Their top areas of expertise are Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Non-Hodgkin Lymphoma.

Their clinical research consists of co-authoring 95 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Warts.

Locations

Hamburg, HH, Germany
Other Locations
Berlin, BE, Germany
Krefeld, NW, Germany
Schwerin, MV, Germany
Aachen, NW, Germany
Universitätsklinik Würzburg
Wuerzburg, BY, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized Phase I / II Open Label, Multicentre Study of Encorafenib Plus Binimetinib and PD-1 Antibody Pembrolizumab in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma
A Randomized Phase I / II Open Label, Multicentre Study of Encorafenib Plus Binimetinib and PD-1 Antibody Pembrolizumab in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma
Enrollment Status: Completed
Publish Date: February 16, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2

95 Total Publications

Corrigendum to 'Resistance of Cutaneous Anaplastic Large-Cell Lymphoma Cells to Apoptosis by Death Ligands Is Enhanced by CD30-Mediated Overexpression of c-FLIP': Journal of Investigative Dermatology, Volume 130, Issue 3, March 2010, Pages 826-840.
Corrigendum to 'Resistance of Cutaneous Anaplastic Large-Cell Lymphoma Cells to Apoptosis by Death Ligands Is Enhanced by CD30-Mediated Overexpression of c-FLIP': Journal of Investigative Dermatology, Volume 130, Issue 3, March 2010, Pages 826-840.
Journal: The Journal of investigative dermatology
Published: November 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Assaf's expertise for a condition
ConditionClose
View All 11 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile